Early research (Phase 1)Study completedNCT01904279
What this trial is testing
Subcutaneously (SC) Administered Tocilizumab (TCZ) in Participants With Polyarticular-Course Juvenile Idiopathic Arthritis (pJIA)
Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 52